Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

Biogen's other Alzheimer's drug fails in late-stage trial

Less than two weeks after the historic approval of Aduhelm, a different Alzheimer's disease drug developed by Biogen Inc. (Nasdaq: BIIB) has failed in a late-stage clinical trial.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.